Jenny Tan

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth

F. Michael Yakes, Jason Chen, Jenny Tan et al. · Molecular Cancer Therapeutics · 2011 · 1.3K citations · Full text

Angiogenesis, Novel Met, Medicine +13

Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases

Fawn Qian, Stefan Engst, Peiwen Yu et al. · Cancer Research · 2009 · 336 citations

Tumor Cell Growth, Novel Inhibitor, Vegf Receptor 2 +16

Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development.

Jenny Tan, John Dunn, Jaak Jaeken et al. · PubMed · 1996 · 156 citations

Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis

Yibin Wang, Jenny Tan, Mark Sutton‐Smith et al. · Glycobiology · 2001 · 135 citations · Full text

Glycobiology, Immunology, Pathology +24

Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of Action

Stéphane De Lombaert, Louis Blanchard, Lisa B. Stamford et al. · Journal of Medicinal Chemistry · 2000 · 100 citations · Full text

Cgs 35066, Selective Non-peptidic Inhibitors, Pharmacotherapy +17